|
Nov 27
|
Acadia Pharmaceuticals Initiates Phase 2 Clinical Trial of ACP-204 for the Treatment of Alzheimer’s Disease Psychosis
|
|
Nov 24
|
Zacks Industry Outlook Highlights Gilead Sciences, CRISPR Therapeutics, ACADIA Pharmaceuticals, Dynavax and Ligand Pharmaceuticals
|
|
Nov 14
|
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
|
Nov 8
|
3 Biotech Stocks With the Strongest Clinical Pipelines
|
|
Nov 4
|
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q3 2023 Earnings Call Transcript
|
|
Nov 2
|
ACADIA Pharmaceuticals Inc. Reports Record Revenues in Q3 2023
|
|
Nov 2
|
Acadia Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operating Overview
|
|
Oct 31
|
Acadia Pharmaceuticals to Participate in the Guggenheim Securities 5th Annual Inflammation & Immunology Conference
|
|
Sep 19
|
Acadia Pharmaceuticals Appoints Albert Kildani as Senior Vice President, Investor Relations and Corporate Communications
|
|
Sep 18
|
When Can We Expect A Profit From ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)?
|
|
Aug 4
|
Puma Biotech (PBYI) Q2 Earnings Beat, Nerlynx Sales Outperform
|